AEGiS-NYT: 8 States Cut From System That Tracks Rate of H.I.V. New York TimesImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


8 States Cut From System That Tracks Rate of H.I.V.

The New York Times - August 23, 2008
Shaila Dewan


ATLANTA -- Eight states and Puerto Rico will no longer receive federal money for an advanced H.I.V. monitoring system that showed that the annual infection rate in the nation was 40 percent higher than previously estimated, officials at the Centers for Disease Control and Prevention said Friday.

The change will lower the number of jurisdictions using the system to 25, from 34, just as health departments are struggling to react to the news, released earlier this month, that the spread of AIDS is far worse than they had thought.

The jurisdictions that lost financing were Georgia, Illinois, Maryland, Missouri, Ohio, Oklahoma, Pennsylvania, Tennessee and Puerto Rico.

Terry Butler, a spokeswoman for the National Center for H.I.V., S.T.D. and TB Prevention at the centers, said that the total money for the system -- which is awarded to applicants on a competitive basis -- would remain the same, but that the remaining 25 participating states and cities would receive more. Ms. Butler said those participants had the most reliable systems and could help the centers produce the best estimates.

The system uses a new test that distinguishes recent infections from old ones, helping epidemiologists track them in something much closer to real time than was previously possible.

Julie Scofield, the executive director of the National Alliance of State and Territorial AIDS Directors, said that over all, money for tracking H.I.V. infections and trends had decreased and that states were struggling to keep up. Ms. Scofield estimated that the money lost by the nine jurisdictions was about $3 million.

"Surveillance funding is starving at the C.D.C.," Ms. Scofield said. "Their ability to say that they're going to have ongoing reliable reports of incidence is somewhat questionable unless you have funding for that."

The alliance has called for a $35 million increase in surveillance financing.

The new H.I.V. report did not use data from all 34 jurisdictions, only the 22 with data that met scientists' standards, Ms. Butler said. Future monitoring will use data from all 25 jurisdictions.

But Ms. Scofield said that using fewer jurisdictions would make more extrapolations necessary to get national estimates for infection rates.

Dr. Carlos del Rio, the co-director of the Emory Center for AIDS Research in Atlanta, said Georgia's loss of money was unfortunate.

"If you're trying to find an enemy like H.I.V.," Dr. del Rio said, "you want to have as much information as you possibly can."
080823
NYT080816


Copyright © 2008 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .